ZLZongqing Lu

Zongqing Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zongqing Lu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Di Jia

    The 2nd Department of Intensive Care Unit, Second Affiliated Hospital of Anhui Medical University, Hefei, China

    1 shared publication
  • Dunling Xia

    Department of Emergency Medicine First Affiliated Hospital of Anhui Medical University Hefei 230022 China

    1 shared publication
  • Gengyun Sun

    Department of Respiratory and Critical Care Medicine The First Affiliated Hospital of Anhui Medical University Hefei 230022 China

    1 shared publication
  • Haijian Cai

    Center for Scientific Research Anhui Medical University Hefei 230032 China

    1 shared publication
  • Jin Zhang

    The 2nd Department of Intensive Care Unit, Second Affiliated Hospital of Anhui Medical University, Hefei, China

    1 shared publication
  • Jingjing Pan

    Department of Respiratory Intensive Care Unit Anhui Chest Hospital Hefei 230022 China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Lactylation of Histone H3k18 and Egr1 Promotes Endothelial Glycocalyx Degradation in Sepsis‐Induced Acute Lung Injury

    by Zongqing Lu, Pu Fang, Shuai Li, Dunling Xia, Jingjing Zhang, Xianghui Wu, Jingjing Pan, Haijian Cai, Lin Fu, Gengyun Sun, et al.

    Circulating lactate is a critical biomarker for sepsis‐induced acute lung injury (S‐ALI) and is strongly associated with poor prognosis. However, whether elevated lactate directly promotes S‐ALI and the specific mechanism involved remain unclear. Here, this work shows that lactate causes pulmonary endothelial glycocalyx degradation and worsens ALI during sepsis. Mechanistically, lactate increases the lactylation of K18 of histone H3, which is enriched at the promoter of EGR1 and promotes its transcription, leading to upregulation of heparanase in pulmonary microvascular endothelial cells. In addition, multiple lactylation sites are identified in EGR1, and lactylation is confirmed to occur mainly at K364. K364 lactylation of EGR1 facilitates its interaction with importin‐α, in turn promoting its nuclear localization. Importantly, this work identifies KAT2B as a novel lactyltransferase whose GNAT domain directly mediates the lactylation of EGR1 during S‐ALI. In vivo, suppression of lactate production or genetic knockout of EGR1 mitigated glycocalyx degradation and ALI and improved survival outcomes in mice with polymicrobial sepsis. Therefore, this study reveals that the crosstalk between metabolic reprogramming in endothelial cells and epigenetic modifications plays a critical role in the pathological processes of S‐ALI.


  • Open Access

    Efficacy and safety of abdominal paracentesis drainage on patients with acute pancreatitis: a systematic review and meta-analysis

    by Zongqing Lu, Xingxing Zhu, Tianfeng Hua, Jin Zhang, Wenyan Xiao, Di Jia, Min Yang

    Objectives To conduct a systematic review and meta-analysis of the efficacy and safety of abdominal paracentesis drainage (APD) in patients with acute pancreatitis (AP) when compared with conventional ‘step-up’ strategy based on percutaneous catheter drainage (PCD). Design Systematic review and meta-analysis. Methods PubMed, EMBASE, Cochrane Library, MEDLINE (OVID), China National Knowledge Infrastructure and Wanfang Database were electronically searched to collect cohort studies and randomised controlled trials (RCTs) from inception to 25 July 2020. Studies related to comparing APD with conventional ‘step-up’ strategy based on PCD were included. Outcomes The primary outcome was all-cause mortality. The secondary outcomes were the rate of organ dysfunction, infectious complications, hospitalisation expenses and length of hospital stay. Results Five cohort studies and three RCTs were included in the analysis. Compared with the conventional ‘step-up’ method, pooled results suggested APD significantly decreased all-cause mortality during hospitalisation (cohort studies: OR 0.48, 95% CI 0.26 to 0.89 and p=0.02), length of hospital stay (cohort studies: standard mean difference (SMD) −0.31, 95% CI −0.53 to –0.10 and p=0.005; RCTs: SMD −0.45, 95% CI −0.64 to –0.26 and pConclusions The findings suggest that early application of APD in patients with AP is associated with reduced all-cause mortality, expenses during hospitalisation and the length of stay compared with the ‘step-up’ strategy without significantly increasing the risk of infectious complications. These results must be interpreted with caution because of the limited number of included studies as well as a larger dependence on observational trials. PROSPERO registration number CRD42020168537.